Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 127

1.

Landscape of Acquired Resistance to Osimertinib in EGFR-Mutant NSCLC and Clinical Validation of Combined EGFR and RET Inhibition with Osimertinib and BLU-667 for Acquired RET Fusion.

Piotrowska Z, Isozaki H, Lennerz JK, Gainor JF, Lennes IT, Zhu VW, Marcoux N, Banwait MK, Digumarthy SR, Su W, Yoda S, Riley AK, Nangia V, Lin JJ, Nagy RJ, Lanman RB, Dias-Santagata D, Mino-Kenudson M, Iafrate AJ, Heist RS, Shaw AT, Evans EK, Clifford C, Ou SI, Wolf B, Hata AN, Sequist LV.

Cancer Discov. 2018 Dec;8(12):1529-1539. doi: 10.1158/2159-8290.CD-18-1022. Epub 2018 Sep 26.

PMID:
30257958
2.

Protocol Design for the Bench to Bed Trial in Alectinib-Refractory Non-Small-Cell Lung Cancer Patients Harboring the EML4-ALK Fusion Gene (ALRIGHT/OLCSG1405).

Isozaki H, Hotta K, Ichihara E, Takigawa N, Ohashi K, Kubo T, Ninomiya T, Ninomiya K, Oda N, Yoshioka H, Ichikawa H, Inoue M, Takata I, Shibayama T, Kuyama S, Sugimoto K, Harada D, Harita S, Sendo T, Tanimoto M, Kiura K.

Clin Lung Cancer. 2016 Nov;17(6):602-605. doi: 10.1016/j.cllc.2016.05.005. Epub 2016 Jun 2.

PMID:
27405684
3.

Synergistic effect of pacritinib with erlotinib on JAK2-mediated resistance in epidermal gowth factor receptor mutation-positive non-small cell lung Cancer.

Ochi N, Isozaki H, Takeyama M, Singer JW, Yamane H, Honda Y, Kiura K, Takigawa N.

Exp Cell Res. 2016 Jun 10;344(2):194-200. doi: 10.1016/j.yexcr.2016.05.008. Epub 2016 May 11.

PMID:
27180268
4.

Diminished Gastric Resection Preserves Better Quality of Life in Patients with Early Gastric Cancer.

Isozaki H, Matsumoto S, Murakami S, Takama T, Sho T, Ishihara K, Sakai K, Takeda M, Nakada K, Fujiwara T.

Acta Med Okayama. 2016;70(2):119-30.

5.

Non-Small Cell Lung Cancer Cells Acquire Resistance to the ALK Inhibitor Alectinib by Activating Alternative Receptor Tyrosine Kinases.

Isozaki H, Ichihara E, Takigawa N, Ohashi K, Ochi N, Yasugi M, Ninomiya T, Yamane H, Hotta K, Sakai K, Matsumoto K, Hosokawa S, Bessho A, Sendo T, Tanimoto M, Kiura K.

Cancer Res. 2016 Mar 15;76(6):1506-16. doi: 10.1158/0008-5472.CAN-15-1010. Epub 2015 Dec 30.

6.

Downregulation of TBXAS1 in an iron-induced malignant mesothelioma model.

Minami D, Takigawa N, Kato Y, Kudo K, Isozaki H, Hashida S, Harada D, Ochi N, Fujii M, Kubo T, Ohashi K, Sato A, Tanaka T, Hotta K, Tabata M, Toyooka S, Tanimoto M, Kiura K.

Cancer Sci. 2015 Oct;106(10):1296-302. doi: 10.1111/cas.12752. Epub 2015 Sep 19.

7.

Programmed cell death protein 1 and programmed death-ligand 1 are expressed on the surface of some small-cell lung cancer lines.

Yamane H, Isozaki H, Takeyama M, Ochi N, Kudo K, Honda Y, Yamagishi T, Kubo T, Kiura K, Takigawa N.

Am J Cancer Res. 2015 Mar 15;5(4):1553-7. eCollection 2015.

8.

Mechanisms of Acquired Resistance to ALK Inhibitors and the Rationale for Treating ALK-positive Lung Cancer.

Isozaki H, Takigawa N, Kiura K.

Cancers (Basel). 2015 Apr 30;7(2):763-83. doi: 10.3390/cancers7020763. Review.

9.

Cisplatin-induced hyponatremia in malignancy: comparison between brand-name and generic formulation.

Ochi N, Yamane H, Hotta K, Fujii H, Isozaki H, Honda Y, Yamagishi T, Kubo T, Tanimoto M, Kiura K, Takigawa N.

Drug Des Devel Ther. 2014 Dec 3;8:2401-8. doi: 10.2147/DDDT.S71419. eCollection 2014.

10.

Skin involvement in diffuse large B-cell lymphoma detected using positron emission tomography.

Yamane H, Ochi N, Isozaki H, Yamagishi T, Honda Y, Takigawa N.

Thorac Cancer. 2014 Nov;5(6):581-2. doi: 10.1111/1759-7714.12149. Epub 2014 Oct 23. No abstract available.

11.

A new human lung adenocarcinoma cell line harboring the EML4-ALK fusion gene.

Isozaki H, Yasugi M, Takigawa N, Hotta K, Ichihara E, Taniguchi A, Toyooka S, Hashida S, Sendo T, Tanimoto M, Kiura K.

Jpn J Clin Oncol. 2014 Oct;44(10):963-8. doi: 10.1093/jjco/hyu110. Epub 2014 Aug 28.

PMID:
25170107
12.

Primary osteosarcoma of the breast.

Murakami S, Isozaki H, Shou T, Sakai K, Yamamoto Y, Oomori M, Toyoda H.

Pathol Int. 2009 Feb;59(2):111-5. doi: 10.1111/j.1440-1827.2008.02338.x.

PMID:
19154266
13.

Foregut duplication cyst of the stomach with pseudostratified columnar ciliated epithelium.

Murakami S, Isozaki H, Shou T, Sakai K, Toyota H.

Pathol Int. 2008 Mar;58(3):187-90. doi: 10.1111/j.1440-1827.2007.02209.x.

PMID:
18251783
14.

Microsatellite instability and clinicopathological features in esophageal squamous cell cancer.

Matsumoto Y, Nagasaka T, Kambara T, Hoshizima N, Murakami J, Sasamoto H, Hosokawa M, Naomoto Y, Isozaki H, Shimizu K, Tanaka N, Matsubara N.

Oncol Rep. 2007 Nov;18(5):1123-7.

PMID:
17914562
15.

Usefulness of preoperative FDG-PET for detection of gastric cancer.

Mukai K, Ishida Y, Okajima K, Isozaki H, Morimoto T, Nishiyama S.

Gastric Cancer. 2006;9(3):192-6.

PMID:
16952037
16.

Allele-specific methylation analysis on upstream promoter region of H19 by methylation-specific PCR with confronting two-pair primers.

Sasamoto H, Nagasaka T, Notohara K, Ozaki K, Isozaki H, Tanaka N, Matsubara N.

Int J Oncol. 2004 Nov;25(5):1273-8.

PMID:
15492815
17.

An assessment of the feasibility of sentinel lymph node-guided surgery for gastric cancer.

Isozaki H, Kimura T, Tanaka N, Satoh K, Matsumoto S, Ninomiya M, Ohsaki T, Mori M; Esophagus Gastrointestinal Surgical Treatment Study Group.

Gastric Cancer. 2004;7(3):149-53.

PMID:
15449202
18.

Allelic loss of a common microsatellite marker MYCL1: a useful prognostic factor of poor outcomes in colorectal cancer.

Kambara T, Sharp GB, Nagasaka T, Takeda M, Sasamoto H, Nakagawa H, Isozaki H, MacPhee DG, Jass JR, Tanaka N, Matsubara N.

Clin Cancer Res. 2004 Mar 1;10(5):1758-63.

19.

Postoperative evaluation of function-preserving gastrectomy for early gastric cancer.

Nomura E, Isozaki H, Fujii K, Toyoda M, Niki M, Sako S, Mabuchi H, Nishiguchi K, Tanigawa N.

Hepatogastroenterology. 2003 Nov-Dec;50(54):2246-50.

PMID:
14696509
20.

Hypermethylation of O6-methylguanine-DNA methyltransferase promoter may predict nonrecurrence after chemotherapy in colorectal cancer cases.

Nagasaka T, Sharp GB, Notohara K, Kambara T, Sasamoto H, Isozaki H, MacPhee DG, Jass JR, Tanaka N, Matsubara N.

Clin Cancer Res. 2003 Nov 1;9(14):5306-12.

21.

[Vascular dementia with a suspicion of Alzheimer's disease in early stage(clinical conference)].

Suda N, Isozaki H, Sakuishi K, Mochizuki Y, Mizutani T, Hirai T.

No To Shinkei. 2002 Jul;54(7):631-9. Japanese. No abstract available.

PMID:
12187725
22.
23.

Diffuse submucosal cysts of the stomach associated with gastric cancer: contribution of Helicobacter pylori infections.

Nakao A, Sato S, Nabeyama A, Sakagami K, Isozaki H, Tanaka N.

Anticancer Res. 2001 Sep-Oct;21(5):3711-5.

PMID:
11848549
24.

Effect of naturally occurring E2F-4 alterations on transcriptional activation and proliferation in transfected cells.

Takashima H, Matsumoto Y, Matsubara N, Shirakawa Y, Kawashima R, Tanino M, Ito S, Isozaki H, Ouchida M, Meltzer SJ, Shimizu K, Tanaka N.

Lab Invest. 2001 Nov;81(11):1565-73.

PMID:
11706064
25.

Leiomyosarcoma arising in a remnant esophagus after esophagectomy: a case report.

Nakao A, Naomoto Y, Shigemitsu K, Shirakawa Y, Yamatsuji T, Haisa M, Takaoka M, Isozaki H, Ohara N, Notohara K, Tanaka N.

Jpn J Clin Oncol. 2001 Oct;31(10):517-21. Review.

PMID:
11696624
26.

High frequency of low-level microsatellite instability in early colorectal cancer.

Kambara T, Matsubara N, Nakagawa H, Notohara K, Nagasaka T, Yoshino T, Isozaki H, Sharp GB, Shimizu K, Jass J, Tanaka N.

Cancer Res. 2001 Nov 1;61(21):7743-6.

27.

Blood transfusion and postoperative plasma cytokine antagonist levels in colorectal cancer patients.

Iwagaki H, Yagi T, Urushihara N, Morimoto Y, Jikuhara A, Isozaki H, Tanaka N.

Hepatogastroenterology. 2001 Sep-Oct;48(41):1351-4.

PMID:
11677962
28.

Successful resection of rectal carcinoma in an Evans' syndrome patient followed by predonisolone and high-dose immunoglobulin: report of a case.

Nakao A, Iwagaki H, Notohara K, Morimoto Y, Ariki N, Kanagawa T, Isozaki H, Tanaka N.

Acta Med Okayama. 2001 Aug;55(4):253-7.

29.

Improvement of the prognosis of gastric cancer with extensive serosal invasion using left upper abdominal evisceration.

Isozaki H, Tanaka N, Fujii K, Tanigawa N, Okajima K.

Hepatogastroenterology. 2001 Jul-Aug;48(40):1179-82.

PMID:
11490828
30.

Genetic alterations of candidate tumor suppressor ING1 in human esophageal squamous cell cancer.

Chen L, Matsubara N, Yoshino T, Nagasaka T, Hoshizima N, Shirakawa Y, Naomoto Y, Isozaki H, Riabowol K, Tanaka N.

Cancer Res. 2001 Jun 1;61(11):4345-9.

31.

A family of multiple endocrine neoplasia type 2A with the RET proto-oncogene mutation in codon 618 (Cys-->Arg).

Nakao A, Naomoto Y, Kataoka M, Haisa M, Kataoka K, Saitoh S, Fujiwara T, Yamatsuji T, Shigemitsu K, Umeoka T, Isozaki H, Futami H, Yamaguchi K, Tanaka N.

Jpn J Clin Oncol. 2001 Apr;31(4):157-61.

PMID:
11386462
32.

Advanced gastric cancer with multiple lymph node metastasis successfully treated with etoposide, adriamycin and cisplatin.

Shigemitsu K, Naomoto Y, Matsuno T, Gochi A, Isozaki H, Tanaka N.

J Gastroenterol Hepatol. 2001 May;16(5):581-5.

PMID:
11350560
33.

Effect of translocation of cirrhotic liver on hepatic venous hemoglobin oxygen saturation during hepatectomy.

Koguchi K, Matsubara N, Hamazaki K, Nowak G, Isozaki H, Tanaka N.

Hepatogastroenterology. 2001 Jan-Feb;48(37):174-8.

PMID:
11268959
34.

Evaluation of endoscopic mucosal resection for superficial esophageal carcinoma.

Noguchi H, Naomoto Y, Kondo H, Haisa M, Yamatsuji T, Shigemitsu K, Aoki H, Isozaki H, Tanaka N.

Surg Laparosc Endosc Percutan Tech. 2000 Dec;10(6):343-50.

PMID:
11147906
35.

Acute appendicitis caused by amebiasis.

Gotohda N, Itano S, Okada Y, Horiki S, Endo A, Terada N, Isozaki H, Takakura N, Tanaka N.

J Gastroenterol. 2000;35(11):861-3. Review.

PMID:
11085496
36.

Multiple tumors and a novel E2F-4 mutation. A case report.

Matsubara N, Yoshitaka T, Matsuno T, Ikeda M, Isozaki H, Tanaka N, Shimizu K.

Digestion. 2000;62(2-3):213-6.

PMID:
11025371
37.

Spontaneous rupture of hepatocellular carcinoma of the caudate lobe.

Nakao A, Matsuda T, Koguchi K, Funabiki S, Mori T, Kobashi K, Takakura N, Isozaki H, Tanaka N.

Anticancer Res. 2000 May-Jun;20(3B):2223-7.

PMID:
10928182
38.

[Genetic analysis for colorectal cancer: what can we learn from microsatellite research?].

Matsubara N, Isozaki H, Tanaka N.

Nihon Geka Gakkai Zasshi. 2000 Jun;101(6):468-75. Review. Japanese.

PMID:
10919157
39.

Multiple hepatic adenomas caused by long-term administration of androgenic steroids for aplastic anemia in association with familial adenomatous polyposis.

Nakao A, Sakagami K, Nakata Y, Komazawa K, Amimoto T, Nakashima K, Isozaki H, Takakura N, Tanaka N.

J Gastroenterol. 2000;35(7):557-62.

PMID:
10905366
40.

The farthest 3' distal end APC mutation identified in attenuated adenomatous polyposis coli with extracolonic manifestations.

Matsubara N, Isozaki H, Tanaka N.

Dis Colon Rectum. 2000 May;43(5):720-1. No abstract available.

PMID:
10826438
41.

Generalized peritonitis due to spontaneously perforated pyometra presenting as pneumoperitoneum: report of a case.

Nakao A, Mimura H, Fujisawa K, Ezawa K, Okamoto T, Iwagaki H, Isozaki H, Takakura N, Tanaka N.

Surg Today. 2000;30(5):454-7. Review.

PMID:
10819486
42.

Gastric perforation caused by a bulimic attack in an anorexia nervosa patient: report of a case.

Nakao A, Isozaki H, Iwagaki H, Kanagawa T, Takakura N, Tanaka N.

Surg Today. 2000;30(5):435-7. Review.

PMID:
10819480
43.

Creation and use of a composite polyurethane-expanded polytetrafluoroethylene graft for hemodialysis access.

Nakao A, Miyazaki M, Oka Y, Matsuda H, Oishi M, Kokumai Y, Kunitomo K, Isozaki H, Tanaka N.

Acta Med Okayama. 2000 Apr;54(2):91-4.

44.

Crohn's disease mimicking as bowel endometriosis. Are the symptoms reduced by nafarelin acetate?

Nakao A, Iwagaki H, Kanagawa T, Jikuhara A, Matsubara N, Takakura N, Isozaki H, Tanaka N.

Arch Gynecol Obstet. 2000 Feb;263(3):131-3.

PMID:
10763842
45.
46.

Portal venous gas associated with splenic abscess secondary to colon cancer.

Nakao A, Iwagaki H, Isozaki H, Kanagawa T, Matsubara N, Takakura N, Tanaka N.

Anticancer Res. 1999 Nov-Dec;19(6C):5641-4.

PMID:
10697633
47.

Immunohistochemical studies of colorectal cancers that developed following pelvic irradiation.

Nakao A, Iwagaki H, Yoshino T, Jikuhara A, Kanagawa T, Kimura T, Matsubara N, Isozaki H, Takakura N, Tanaka N.

Surg Today. 2000;30(2):117-21.

PMID:
10664332
48.

Gallbladder torsion: case report and review of 245 cases reported in the Japanese literature.

Nakao A, Matsuda T, Funabiki S, Mori T, Koguchi K, Iwado T, Matsuda K, Takakura N, Isozaki H, Tanaka N.

J Hepatobiliary Pancreat Surg. 1999;6(4):418-21. Review.

PMID:
10664294
49.

Modulatory effect of a serine protease inhibitor on surgical stress: its clinical implications.

Iwagaki H, Yagi T, Urushihara N, Kobashi K, Morimoto Y, Isozaki H, Takakura N, Tanaka N.

Acta Med Okayama. 1999 Oct;53(5):239-44.

PMID:
10561733
50.

Prognostic factors of advanced gastric carcinoma without serosal invasion (pT2 gastric carcinoma).

Isozaki H, Fujii K, Nomura E, Mabuchi H, Nishiguchi K, Hara H, Tanigawa N.

Hepatogastroenterology. 1999 Jul-Aug;46(28):2669-72.

PMID:
10522062

Supplemental Content

Loading ...
Support Center